Health News Archive - May 11, 2010
LONDON, May 11 /PRNewswire/ -- Silence Therapeutics plc (AIM: SLN) ("Silence" or the "Company") announces that Philip Haworth, Ph.D., chief executive officer, will present corporate updates at two upcoming industry and financial conferences. Dr.
VIENNA, May 11 /PRNewswire-FirstCall/ -- Today, the biotech-vaccine company Intercell AG (VSE: ICLL) announced its financial results for Q1 and presented an update on the Company's development programs. Financial Results EUR 4.8m revenues in Q1 2010 compared to EUR 5.4m in Q1 2009.IXIAROÂ®/JESPECTÂ® product sales in line with Q1 2009 reflecting low level of new product supplies in Q1 2010; new product supplies to marketing and distribution partners shifted from Q1 to Q2 2010 due to supply-planning and lot release timing.EUR 14.7m net loss for Q1 2010 compared to EUR 8.2m in Q1 2009.EUR 17.9m R&D expenses in Q1 2010 - up 19.1 percent compared to EUR 15.1m in Q1 2009 - mainly due to late-stage research and development costs for the TD vaccine patch.Strong cash position: EUR 158.2m in liquid funds at March 31, 2010. Key Financial Figures 3 months ended Year ended EUR in thousands -------------- -----
ATLANTA, May 11 /PRNewswire/ -- Hothead Technologies has executed an agreement with Shafer Medical Devices, a Division of Shafer Enterprises, LLC to develop and distribute a medical application of the H.O.T.(TM) System that supports the Shafer Medical Devices Hypo/Hyperthermic Pad in managing normothermia in patients, during pre-op, surgery, and post op.
SHENYANG, China, May 11 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX) ("3SBio" or "the Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it will release unaudited financial results for the first quarter ended March 31, 2010 on May 16, 2010 at 8:00pm (Eastern). Following the earnings announcement, 3SBio's senior management will host a conference call at 5:00 am (Pacific) / 8:00 am (Eastern) / 8:00 pm (Beijing/Hong Kong) on May 17, 2010 to discuss its 2010 first quarter financial results and recent business activity. The conference call may be accessed using the dial-in numbers below: Conference ID: 74760426 Local dial-in: China - landline 800 819 0121 China - mobile 400 620 8038 Hong Kong - 852 2475 0994 International toll-free dial-in: Hong Kong 800 930 346 United Kingdom 080 8234 6646 United States 1 866 519 4
HAIKOU CITY, China, May 11 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc.
BOSTON, May 11 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (Nasdaq: PRXL), a leading global biopharmaceutical services provider, announced today that Alberto Grignolo, Ph.D., Corporate Vice President, Global Strategy and Services at PAREXEL Consulting, will chair a session entitled "Global Clinical Development and Best Regulatory Meeting Practices in the United States, European Union, Japan and China" on May 19, 2010 at the 2nd DIA China Annual Meeting.
MONTCLAIR, N.J., May 11 /PRNewswire/ -- Dr. Lisa Sanders will deliver the keynote address at PAINWeekÂ® 2010. Dr. Sanders' monthly Diagnosis column in The New York Times Magazine was an inspiration for the hit Fox TV series House, M.D. Dr.
HACKENSACK, N.J., May 11 /PRNewswire/ -- Soft & Shield Hand Sanitizer and Moisturizer is a new alcohol-free hand sanitizer that contains ingredients that soften, smooth and moisturize the skin.
WILMINGTON, Mass., May 11 /PRNewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc.Â® (NASDAQ GM: DUSA), a dermatology company that is developing and marketing LevulanÂ® Photodynamic Therapy (PDT) and other products focused on patients with common skin conditions, reported today its corporate highlights and financial results for the first quarter ended March 31, 2010. Highlights for the first quarter include: Total product revenues were $8.7 million for the quarter, representing a $1.6 million or 22% year-over-year improvement.
CINCINNATI, May 11 /PRNewswire/ -- Fruit2OÂ® water, the original zero-calorie, fruit-flavored water, is partnering with the American Diabetes Association to help promote the fight to stop diabetes.
- A poem in which the author retracts something said in an earlier poem.